Lipodystrophy

Links shared publicly online about this topic

Lipodystrophy, Acquired Partial: eMedicine Endocrinology

emedicine.medscape.com — “Overview: Acquired partial lipodystrophy, also known as Barraquer-Simons syndrome or cephalothoracic lipodystrophy, is one of the rare forms of lipodystrophy. Mitchell initially reported this variety in 1885.1 Barraquer and Simons further characterized the syndrome at the ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on May 5, 2010 at 7:15 pm By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

A rare form of lipodystrophy, acquired partial lipodystrophy is also known as Barraquer-Simons syndrome. Learn more. http://bit.ly/bRKpTp

2 years ago...

Lipodystrophy, Progressive: eMedicine Dermatology

emedicine.medscape.com — “Overview: Lipodystrophy syndromes represent a group of rare, heterogeneous disorders characterized by progressive loss of fat tissue, mainly from the subcutaneous compartment and occasionally from visceral fat.1 Subcutaneous loss of fat can occur as generalized or ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 19, 2010 at 6:16 pm By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

Progressive lipodystrophy is a rare condition in which fat accumulates in the upper body progressing downward. http://bit.ly/b5ESai

2 years ago...

Lipodystrophy, Generalized: eMedicine Dermatology

emedicine.medscape.com — “Overview: Generalized lipodystrophy syndrome is the association of acanthosis nigricans (AN) with the generalized complete absence of subcutaneous fat and the presence of muscle hypertrophy, hyperlipemia, diabetes mellitus, and hepatosplenomegaly with cirrhosis. Two forms of this syndrome ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 21, 2010 at 10:20 pm By:

SusanS_Health Susan Scroggins Health Advocate and Active Health Library

Generalized lipodystrophy (or Beradinelli-Seip syndrome) is a rare genetic skin condition. Learn more about it. http://bit.ly/bUAydR

2 years ago...

Lipodystrophy, Localized: eMedicine Dermatology

emedicine.medscape.com — “Overview: Lipodystrophies are a heterogeneous group of diseases clinically characterized by a congenital or acquired loss of fat in circumscribed, partial, or diffuse areas of the body. As a rule, localized lipodystrophies are not associated with metabolic ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 19, 2010 at 6:45 pm By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

The gain or loss of fat in a particular area of the body is generally harmless, though perhaps unsightly. Learn causes. http://bit.ly/cwNzXU

2 years ago...

Lipodystrophy, HIV: eMedicine Dermatology

emedicine.medscape.com — “Overview: HIV-associated lipodystrophy is a syndrome that occurs in individuals with HIV infection who are being treated with antiretroviral medications. Although the term HIV-associated lipodystrophy refers to abnormal central fat accumulation (lipohypertrophy) and localized loss of fat ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 19, 2010 at 6:18 pm By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

HIV patients may experience fat accumulation or fat loss from localized portions of the body. Learn why this happens. http://bit.ly/9EJaDJ

2 years ago...

Egrifta Approved for HIV-Related Lipodystrophy

webmd.com — “The FDA has approved Egrifta, administered by daily injection, for the treatment of HIV lipodystrophy -- fat accumulation that is a side effect of AIDS drugs.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on November 11, 2010 at 11:58 pm By:

WebMD_News WebMD_News Health News

Egrifta OK’d for Excess Fat Due to AIDS Drugs: The FDA has approved Egrifta, administered by daily injection, fo... http://bit.ly/dw8Z2L

1 year ago...

Forum on Nutrition and Exercise: Lipodystrophy Without Meds

thebody.com — “Forum on Nutrition and Exercise: Lipodystrophy Without MedsView full resource at thebody.com

  • View Related
  • Share

Most Recently Shared on May 13, 2010 at 4:02 pm By:

TheBodyDotCom The Body Health Site

Ask the HIV/AIDS Experts: "How Common Is Lipodystrophy in HIVers Not on Meds?" http://bit.ly/csno7O #hiv #aids #lipodystrophy

2 years ago...

Forum on Nutrition and Exercise: Changing meds because of Lipodystrophy

thebody.com — “There is some evidence that switching from Norvir boosted protease inhibitors may, and I say MAY, decrease visceral fat in some patients that have metabolic issues. But in most patients, that is...View full resource at thebody.com

  • View Related
  • Share

Most Recently Shared on April 7, 2011 at 6:00 pm By:

TheBodyDotCom The Body Health Site

Ask the HIV/AIDS Experts: "Am I Doing the Right Things to Reduce My Belly?" http://bit.ly/fPw48j #lipodystrophy #fat

10 months ago...

Endocrinology News & Articles - MDLinx - Lipodystrophy on #MDlinx

mdlinx.com — “Endocrinology News & Articles - MDLinx - Lipodystrophy on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 28, 2010 at 8:45 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Lipodystrophy: Metabolic insights from a rare disorder.: Journal of Endocrinology http://bit.ly/cL7nuR #endo

1 year ago...

Metreleptin controlled diabetes, lipids in patients with lipodystrophy

endocrinetoday.com — “American Association of Clinical Endocrinologists 20th Annual Meeting SAN DIEGO --" Results from a new analysis of an ongoing, long-term reseaView full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on April 15, 2011 at 9:08 pm By:

TheAACE AACE Medical Society

Metreleptin controlled diabetes, lipids in patients with lipodystrophy (Endocrine Today): http://bit.ly/eiUxpG #AACE11

10 months ago...

Lipodystrophy in HIV Disease | Consumer Health Video Library - Heath Video

healthvideo.com — “Lipodystrophy in HIV DiseaseView full resource at healthvideo.com

  • View Related
  • Share

Most Recently Shared on August 18, 2009 at 3:24 pm By:

Medicare Expands Coverage For Treating Facial Lipodystrophy Syndrome In People Living With HIV

medicalnewstoday.com — “The Centers for Medicare & Medicaid Services (CMS) announced its decision to cover facial injections for Medicare beneficiaries who experience symptoms of depression due to the stigmatizing appearView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2010 at 9:37 pm By:

medical_tweets medical_tweets Health News

Medicare Expands Coverage For Treating Facial Lipodystrophy Syndrome In People Living With HIV The Centers for Medica.. http://bit.ly/c8JaZV

2 years ago...

FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV - The Body

thebody.com — “On November 10, 2010, the Food and Drug Administration approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which ...View full resource at thebody.com

  • View Related
  • Share

Most Recently Shared on November 11, 2010 at 1:01 pm By:

TheBodyDotCom The Body Health Site

FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV http://www.thebody.com/content/art59376.html?tw #aids #fat #hump

1 year ago...

Tesamorelin Approved to Treat Lipodystrophy in HIV Patients : Internal Medicine News

internalmedicinenews.com — “Tesamorelin Approved to Treat Lipodystrophy in HIV Patients : Internal Medicine NewsView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on November 11, 2010 at 6:13 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

FDA approves tesamorelin to treat lipodystrophy in HIV patients, @elizmech reports. http://bit.ly/dxPVix

1 year ago...

Egrifta approved for HIV-associated abdominal lipodystrophy - ONA

oncologynurseadvisor.com — “Merck and EMD Serono announced that the FDA has approved Egrifta (tesamorelin for injection), a growth hormone releasing factor (GRF) analog, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on November 11, 2010 at 4:18 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • J_Bohlen

    Julie Bohlen

    Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.

    View Profile

  • J_Bohlen

    Julie Bohlen

    Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.

    View Profile

  • SusanS_Health

    Susan Scroggins

    Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390